College seattle

The Center for Military Biomaterials Inquire into (CeMBR), part of the New Jersey Center in regard to Biomaterials at Rutgers University, has enabled the development of a breakthrough spray-on dressing for injuries. The trademarked GelSpray Liquid Bandage by BioCure Inc., a medical device company in Norcross, Ga., received endorsement for the duration of marketing from the U.S. Food and Drug Administration (FDA) Feb. 1.

The GelSpray Liquid Bandage is a major appreciation in the directorship and punctiliousness of combat disaster and civilian wounds. Much like epoxy is dispensed in household kits, the dressing is applied with a dual syringe that releases two polymer ingredients. These polymers retort rapidly upon mixing to forge a gel-based dressing that frontline warfare soldiers can apply to their own wounds. The dressing conforms to the swaddle geometry, adheres to undiminished skin but not directly to the injured tissue, and resists abrasion.

While created as a service to the military, the GelSpray technology has potential uses in civilian health care. Prospective versions of the liquefied bandage may be fit for reason by civilian rescue teams to therapy traumatic wounds and burns, as well as in the treatment of diabetic ulcers, ostomies and post-op wounds. Tomorrow’s products based on the GelSpray technology platform will take in bustling ingredients to survey infection and pain, and control severe bleeding.

Rutgers’ Center for Military Biomaterials Research was created to constituent academia, industry and the military to fulfill urgent military medical care needs. Its mission is to familiarize the biomedical research community with the unequalled needs of vendetta casualty care and to foster the maturation of innovative medical technologies to treat injured soldiers. The center is supported with funding from the U.S. Army Medical Research and Materiel Command (USAMRMC) and its Telemedicine and Advanced Technologies Research Center at Fort Detrick, Md.

“In this anyway a lest, it was the mission of our center to collaborate with earnestness to conduct inquire into that resulted in a fresh consequence,” said Joachim Kohn, the principal investigator at CeMBR and Board of Governors Professor of Chemistry at Rutgers.

In the collaboration with BioCure, the Rutgers center supported the investigation take a part in of the outcome evolvement achievement with funding from the USAMRMC. Kohn explained that the close collaboration among BioCure, the U.S. Army and Rutgers moved the project rapidly from concept to FDA market allowance. “The process took about three and a half years - a truly remarkable achievement,” Kohn added.

—————————-
Article adapted by Medical News Today from original press let out.
—————————-

The GelSpray Liquid Bandage was designed in consultation with the U.S. Army Institute of Surgical Research, part of the USAMRMC, while the Rutgers center provided applied guidance based on knowledge of military fallout specification requirements, regulatory issues and polymer chemistry.

Source: Joseph Blumberg

Rutgers University